Nachum welcomed Nadav Kidron, Chief Executive Officer & Director of Israel based Oramed Pharmaceuticals to this morning’s JM in the AM to discuss Oramed and their innovative efforts in the pharmaceutical industry. Nadav explained that Oramed is currently working on creating oral alternatives to medical injections, such as insulin for people dealing with Diabetes. From the Oramed website: “Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection.”